From the Journals

Few transgender teens discontinue hormones in young adulthood


 

Study limitations

She also acknowledges that the short follow-up data in some individuals make it difficult to draw conclusions about regret, to some extent.

The average use of cross-sex hormones in their study was 3.5 years for males transitioning to females and 2.3 years for females transitioning to males, so on average, this wouldn’t be long enough to see regret, she acknowledged.

Prior research shows that if youth decide to detransition to their natal sex, this can take, on average, 5 years from the start of medical therapy among born females and 7 years among born males.

However, some born males in the study had been taking hormones for 20 years and some natal females for 15 years, said Dr. van der Loos.

Another limitation is that the research only followed individuals until the end of 2018 while some government data estimate that the number of teens identifying as transgender has nearly doubled over the past 5 years.

The authors, Dr. Munera, and Dr. Lopez have reported no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Comments open for U.K.’s transgender care guideline
MDedge ObGyn
Pediatricians at odds over gender-affirming care for trans kids
MDedge ObGyn
Medical coding creates barriers to care for transgender patients
MDedge ObGyn
WPATH removes age limits from transgender treatment guidelines
MDedge ObGyn
Gender-affirming mastectomy boosts image and quality of life in gender-diverse youth
MDedge ObGyn
Med groups urge feds to protect physicians from anti-trans violence
MDedge ObGyn
Best practices for an LGBTQ+ friendly medical space
MDedge ObGyn
Cardiac biomarkers track with hormone therapy in transgender people
MDedge ObGyn
Chest reconstruction surgeries up nearly fourfold among adolescents
MDedge ObGyn
Caring for the aging transgender patient
MDedge ObGyn